OmniAb (OABI) Operating Expenses (2021 - 2026)
OmniAb (OABI) reported Operating Expenses of $22.3 million for Q1 2026, down 3.23% year-over-year from $23.0 million in Q1 2025, and down 7.81% quarter-over-quarter from $24.1 million in Q4 2025.
OmniAb (OABI) Operating Expenses (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Operating Expenses data on file, last reported at $22.3 million in Q1 2026.
- Operating Expenses for Q1 2026 came in at $22.3 million, down 3.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $86.9 million (down 10.91% YoY), and the FY2025 annual result was $87.6 million, down 13.14% from the prior year.
- Operating Expenses slipped to $22.3 million in Q1 2026 per OABI's latest filing, from $24.1 million in the prior quarter.
- Over five years, Operating Expenses peaked at $26.7 million in Q4 2024 and troughed at $17.8 million in Q1 2022.
- A 5-year average of $23.5 million and a median of $23.9 million in 2024 frame the typical range for Operating Expenses.
- On a YoY basis, Operating Expenses climbed as much as 904476.66% in 2022 and fell as far as 62.53% in 2022.
- A 5-year view of Operating Expenses shows it stood at $26.3 million in 2022, then slipped by 1.02% to $26.0 million in 2023, then increased by 2.52% to $26.7 million in 2024, then decreased by 9.53% to $24.1 million in 2025, then fell by 7.81% to $22.3 million in 2026.
- Business Quant data shows OABI's Operating Expenses at $22.3 million in Q1 2026, $24.1 million in Q4 2025, and $20.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 22.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.26 Mn |
| Dec 31, 2025 | 24.14 Mn |
| Sep 30, 2025 | 20.38 Mn |
| Jun 30, 2025 | 20.12 Mn |
| Mar 31, 2025 | 23.00 Mn |
| Dec 31, 2024 | 26.68 Mn |
| Sep 30, 2024 | 23.94 Mn |
| Jun 30, 2024 | 23.92 Mn |
| Mar 31, 2024 | 26.35 Mn |
| Dec 31, 2023 | 26.03 Mn |
| Sep 30, 2023 | 25.79 Mn |
| Jun 30, 2023 | 26.39 Mn |
| Mar 31, 2023 | 25.37 Mn |
| Dec 31, 2022 | 26.30 Mn |
| Sep 30, 2022 | 21.82 Mn |
| Jun 30, 2022 | 19.77 Mn |
| Mar 31, 2022 | 17.85 Mn |
| Dec 31, 2021 | 70.18 Mn |
| Sep 30, 2021 | 170,579.00 |
| Jun 30, 2021 | 2,185.00 |